New river blindness drug approved

The United States Food and Drug Administration (FDA) has approved moxidectin as the first new treatment for river blindness in 20 years, adding new ammunition...

US$5M gift to support vision research

Wills Eye Hospital in Philadelphia has been given US$5 million to establish a new vision research centre, named after philanthropists Vickie and Jack Farber,...

Deformation may predict glaucoma prognosis

A recent Seoul University study has found a link between how much the lamina cribrosa - a thin, sieve-like portion of sclera at the base of the optic disc...

New direction for BHVI

Australia’s Brien Holden Vision Institute has announced a change in leadership and a shift in focus to address future needs for both the ophthalmic industry...

Australia funds diabetes screening

The Australian government’s decision to develop a national diabetes eye screening programme is a major step in the fight against diabetes-related vision...

RANZCO: first female president

Dr Heather Mack will become the first female president of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) at the RANZCO Congress...

RANZCO NZ 2018: Conference report

The 2018 RANZCO New Zealand branch annual scientific meeting was held in the heart of Auckland city, at the Hilton Hotel from 11-12 May. Incorporating...

New markers for eye disease

Scientists have discovered 19 new genetic markers that could predict the risk of eye disease, bringing the total number of known variants to 45. The genome-wide...

Bottom Banner Advert